| Trial ID: | L0031 |
| Source ID: | NCT06572215
|
| Associated Drug: |
Dapagliflozin
|
| Title: |
DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve
|
| Acronym: |
DYNAMO
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases
|
| Interventions: |
DRUG: Dapagliflozin
|
| Outcome Measures: |
Primary: Change in eGFR from baseline to 2hours after oral protein load, 2 hours |
|
| Sponsor/Collaborators: |
Sponsor: King's College Hospital NHS Trust | Collaborators: King's College London
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
44
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2023-12-14
|
| Completion Date: |
2025-01-01
|
| Results First Posted: |
|
| Last Update Posted: |
2024-08-27
|
| Locations: |
King's College Hospital, London, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT06572215
|
